Barry J. Simon - 21 May 2021 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role
Director
Signature
/s/ Sonja Nelson, as Attorney-in-Fact
Issuer symbol
IBRX
Transactions as of
21 May 2021
Net transactions value
-$2,018,057
Form type
4
Filing time
25 May 2021, 20:00:37 UTC
Previous filing
07 May 2021
Next filing
28 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBRX Common Stock Sale $241,164 -14,990 -0.46% $16.09 3,212,517 21 May 2021 Direct F1
transaction IBRX Common Stock Sale $340,071 -21,223 -0.66% $16.02 3,191,294 24 May 2021 Direct F2
transaction IBRX Common Stock Sale $1,436,822 -88,787 -2.8% $16.18 3,102,507 25 May 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 14,990 shares sold in the price range of $16.00 to $16.26 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Represents the weighted average share price of an aggregate total of 21,223 shares sold in the price range of $16.00 to $16.115 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 88,787 shares sold in the price range of $16.00 to $16.425 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.